Seiren Co.,Ltd.
Seiren Co.,Ltd. (3569.T) Financial Performance & Income Statement Overview
Review Seiren Co.,Ltd. (3569.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Seiren Co.,Ltd. (3569.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Seiren Co.,Ltd. 3569.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $41.13B | $40.49B | $39.35B | $38.69B |
| Cost of Revenue | $30.07B | $28.65B | $28.63B | $28.29B |
| Gross Profit | $11.07B | $11.84B | $10.72B | $10.40B |
| Gross Profit Ratio | $0.27 | $0.29 | $0.27 | $0.27 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.77B | $6.49B | $6.62B | $6.28B |
| Operating Expenses | $6.77B | $6.49B | $6.62B | $6.28B |
| Total Costs & Expenses | $36.84B | $35.14B | $35.24B | $34.57B |
| Interest Income | $428.00M | $0.00 | $0.00 | $232.00M |
| Interest Expense | $43.00M | $0.00 | $0.00 | $69.00M |
| Depreciation & Amortization | $1.57B | $1.52B | $1.53B | $1.41B |
| EBITDA | $6.38B | $6.88B | $5.63B | $5.53B |
| EBITDA Ratio | $0.16 | $0.17 | $0.14 | $0.14 |
| Operating Income | $4.29B | $5.35B | $4.10B | $4.12B |
| Operating Income Ratio | $0.10 | $0.13 | $0.10 | $0.11 |
| Other Income/Expenses (Net) | $468.00M | $119.00M | $344.00M | $507.00M |
| Income Before Tax | $4.76B | $5.47B | $4.45B | $4.62B |
| Income Before Tax Ratio | $0.12 | $0.14 | $0.11 | $0.12 |
| Income Tax Expense | $1.55B | $1.47B | $1.22B | $1.10B |
| Net Income | $3.19B | $3.99B | $3.21B | $3.50B |
| Net Income Ratio | $0.08 | $0.10 | $0.08 | $0.09 |
| EPS | $54.54 | $66.16 | $55.44 | $63.49 |
| Diluted EPS | $53.35 | $66.16 | $56.64 | $56.92 |
| Weighted Avg Shares Outstanding | $59.80M | $59.01M | $57.81M | $55.21M |
| Weighted Avg Shares Outstanding (Diluted) | $58.49M | $60.26M | $56.58M | $61.58M |
Over the past four quarters, Seiren Co.,Ltd. demonstrated steady revenue growth, increasing from $38.69B in Q1 2024 to $41.13B in Q4 2024. Operating income reached $4.29B in Q4 2024, maintaining a consistent 10% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $6.38B, reflecting operational efficiency. Net income dropped to $3.19B, with EPS at $54.54. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan